The Goldman Sachs Group (NYSE:GS) Stock Price Up 0.7%

→ Trump’s last act as President (From Porter & Company) (Ad)

Shares of The Goldman Sachs Group, Inc. (NYSE:GS - Get Free Report) rose 0.7% on Thursday . The company traded as high as $407.86 and last traded at $406.57. Approximately 778,034 shares changed hands during mid-day trading, a decline of 67% from the average daily volume of 2,342,566 shares. The stock had previously closed at $403.91.

Analyst Ratings Changes

GS has been the topic of a number of recent analyst reports. Oppenheimer raised their price objective on The Goldman Sachs Group from $446.00 to $479.00 and gave the company an "outperform" rating in a research note on Tuesday. HSBC lifted their price target on The Goldman Sachs Group from $460.00 to $470.00 and gave the stock a "buy" rating in a research report on Tuesday. Morgan Stanley raised The Goldman Sachs Group from an "equal weight" rating to an "overweight" rating and lifted their price target for the stock from $333.00 to $449.00 in a research report on Tuesday, January 30th. Evercore ISI lifted their price target on The Goldman Sachs Group from $435.00 to $440.00 and gave the stock an "outperform" rating in a research report on Tuesday. Finally, JPMorgan Chase & Co. lifted their price target on The Goldman Sachs Group from $424.00 to $433.00 and gave the stock an "overweight" rating in a research report on Tuesday. Six investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $434.93.

Get Our Latest Report on GS


The Goldman Sachs Group Stock Down 0.2 %

The firm has a 50-day moving average price of $395.67 and a two-hundred day moving average price of $365.35. The company has a debt-to-equity ratio of 1.98, a current ratio of 1.12 and a quick ratio of 0.76. The company has a market capitalization of $130.82 billion, a price-to-earnings ratio of 15.72, a PEG ratio of 1.54 and a beta of 1.43.

The Goldman Sachs Group (NYSE:GS - Get Free Report) last issued its quarterly earnings results on Monday, April 15th. The investment management company reported $11.58 EPS for the quarter, beating the consensus estimate of $8.54 by $3.04. The Goldman Sachs Group had a return on equity of 8.65% and a net margin of 8.17%. The firm had revenue of $14.21 billion during the quarter, compared to analysts' expectations of $12.94 billion. During the same period in the prior year, the firm posted $8.79 earnings per share. The business's quarterly revenue was up 16.1% compared to the same quarter last year. As a group, sell-side analysts anticipate that The Goldman Sachs Group, Inc. will post 32.76 earnings per share for the current fiscal year.

The Goldman Sachs Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 27th. Stockholders of record on Thursday, May 30th will be given a $2.75 dividend. This represents a $11.00 annualized dividend and a dividend yield of 2.73%. The ex-dividend date of this dividend is Thursday, May 30th. The Goldman Sachs Group's payout ratio is presently 42.95%.

Insider Activity at The Goldman Sachs Group

In other The Goldman Sachs Group news, insider Kathryn H. Ruemmler sold 7,277 shares of the stock in a transaction on Tuesday, January 23rd. The stock was sold at an average price of $379.81, for a total transaction of $2,763,877.37. Following the transaction, the insider now owns 6,501 shares in the company, valued at approximately $2,469,144.81. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other The Goldman Sachs Group news, insider Kathryn H. Ruemmler sold 7,277 shares of the stock in a transaction on Tuesday, January 23rd. The stock was sold at an average price of $379.81, for a total transaction of $2,763,877.37. Following the transaction, the insider now owns 6,501 shares in the company, valued at approximately $2,469,144.81. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Denis P. Coleman sold 12,680 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $394.43, for a total value of $5,001,372.40. Following the sale, the chief financial officer now directly owns 29,417 shares in the company, valued at $11,602,947.31. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 35,907 shares of company stock worth $13,950,851. Insiders own 0.54% of the company's stock.

Institutional Trading of The Goldman Sachs Group

Several large investors have recently bought and sold shares of GS. Capital World Investors raised its position in shares of The Goldman Sachs Group by 6.0% during the fourth quarter. Capital World Investors now owns 6,012,564 shares of the investment management company's stock worth $2,319,470,000 after acquiring an additional 338,181 shares during the last quarter. Morgan Stanley increased its holdings in The Goldman Sachs Group by 40.0% in the fourth quarter. Morgan Stanley now owns 5,936,351 shares of the investment management company's stock worth $2,038,425,000 after purchasing an additional 1,696,350 shares in the last quarter. Fisher Asset Management LLC increased its holdings in The Goldman Sachs Group by 2.8% in the fourth quarter. Fisher Asset Management LLC now owns 5,518,035 shares of the investment management company's stock worth $2,128,693,000 after purchasing an additional 152,474 shares in the last quarter. Massachusetts Financial Services Co. MA grew its stake in The Goldman Sachs Group by 0.5% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 5,195,203 shares of the investment management company's stock valued at $2,004,153,000 after acquiring an additional 27,524 shares during the period. Finally, Price T Rowe Associates Inc. MD grew its stake in The Goldman Sachs Group by 5.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 4,953,461 shares of the investment management company's stock valued at $1,910,897,000 after acquiring an additional 274,989 shares during the period. 71.21% of the stock is owned by institutional investors and hedge funds.

About The Goldman Sachs Group

(Get Free Report)

The Goldman Sachs Group, Inc, a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals worldwide. It operates through Global Banking & Markets, Asset & Wealth Management, and Platform Solutions segments. The Global Banking & Markets segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and relationship lending, and acquisition financing, as well as secured lending, through structured credit and asset-backed lending and involved in financing under securities to resale agreements.

Featured Articles

→ Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad)

Should you invest $1,000 in The Goldman Sachs Group right now?

Before you consider The Goldman Sachs Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Goldman Sachs Group wasn't on the list.

While The Goldman Sachs Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Featured Articles and Offers

Biotech Boom: Stocks Skyrocketing & What's Next

Biotech Boom: Stocks Skyrocketing & What's Next

Dive into biotech's latest trends with Dylan Jovine: weight loss breakthroughs, smart chemo innovations, and expert stock evaluation tips.

Search Headlines: